4038811000001107: Alkeran 2mg tablets (GlaxoSmithKline) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Alkeran 2mg tablets (GlaxoSmithKline)
• \UK product\Virtual medicinal product\Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet\Alkeran 2mg tablets (GlaxoSmithKline)
• \UK product\Virtual therapeutic moiety\Melphalan\Product containing only melphalan in oral dose form (medicinal product form)\Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet\Alkeran 2mg tablets (GlaxoSmithKline)
• \UK product\Virtual therapeutic moiety\Melphalan\Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet\Alkeran 2mg tablets (GlaxoSmithKline)
• \UK product\Trade family\Alkeran\Alkeran 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing alkylating agent\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing melphalan\Melphalan\Product containing only melphalan in oral dose form (medicinal product form)\Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet\Alkeran 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing alkylating agent\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing melphalan\Melphalan\Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet\Alkeran 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing alkylating agent\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing melphalan\Product containing melphalan in oral dose form (medicinal product form)\Product containing only melphalan in oral dose form (medicinal product form)\Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet\Alkeran 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing melphalan\Melphalan\Product containing only melphalan in oral dose form (medicinal product form)\Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet\Alkeran 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing melphalan\Melphalan\Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet\Alkeran 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing nitrogen mustard derivative and acting as antineoplastic agent (product)\Product containing melphalan\Product containing melphalan in oral dose form (medicinal product form)\Product containing only melphalan in oral dose form (medicinal product form)\Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet\Alkeran 2mg tablets (GlaxoSmithKline)
• \Medicinal product\Product manufactured as oral dose form\Product containing melphalan in oral dose form (medicinal product form)\Product containing only melphalan in oral dose form (medicinal product form)\Product containing precisely melphalan 2 milligram/1 each conventional release oral tablet\Alkeran 2mg tablets (GlaxoSmithKline)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
17801101000001112	Alkeran 2mg tablets (GlaxoSmithKline) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
70075201000001110	Alkeran 2mg tablets (Aspen Pharma Trading Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start